| 摘要 |
<p>The invention provides compounds of formula (I) wherein R1, R3, R4, R5, R6, R7, L, X and Y are as defined in the specification; together with processes and intermediates for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase.</p> |
| 申请人 |
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;MURUGAN, ANDIAPPAN;ASHTON, MARK;BERGSTROM, LENA, KRISTINA;KRISTOFFERSSON, ANNA;LINDSJOE, MARTIN;SJOE, PETER, OLOF;MEIGH, JON |
发明人 |
MURUGAN, ANDIAPPAN;ASHTON, MARK;BERGSTROM, LENA, KRISTINA;KRISTOFFERSSON, ANNA;LINDSJOE, MARTIN;SJOE, PETER, OLOF;MEIGH, JON |
